161 related articles for article (PubMed ID: 10634639)
1. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Niitsu N; Umeda M; Honma Y
Leuk Res; 2000 Jan; 24(1):1-9. PubMed ID: 10634639
[TBL] [Abstract][Full Text] [Related]
2. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Niitsu N; Umeda M; Honma Y
Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
[TBL] [Abstract][Full Text] [Related]
3. Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Niitsu N; Yamaguchi Y; Umeda M; Honma Y
Blood; 1998 Nov; 92(9):3368-75. PubMed ID: 9787175
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Honma Y
Leuk Lymphoma; 2001; 42(5):953-62. PubMed ID: 11697650
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
7. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Niitsu N; Honma Y
Leuk Lymphoma; 1999 Jul; 34(3-4):261-71. PubMed ID: 10439363
[TBL] [Abstract][Full Text] [Related]
8. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
Niitsu N; Higashihara M; Honma Y
Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
[TBL] [Abstract][Full Text] [Related]
9. The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
Korycka A; Smolewski P; Robak T
Eur J Haematol; 2004 Dec; 73(6):418-26. PubMed ID: 15522064
[TBL] [Abstract][Full Text] [Related]
10. Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.
Yokoyama A; Okabe-Kado J; Uehara Y; Oki T; Tomoyasu S; Tsuruoka N; Honma Y
Leuk Res; 1996 Jun; 20(6):491-7. PubMed ID: 8709621
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Umeda M; Honma Y
Blood; 2000 Aug; 96(4):1512-6. PubMed ID: 10942399
[TBL] [Abstract][Full Text] [Related]
12. Purine nucleoside analogues in the treatment of myleoid leukemias.
Robak T
Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
[TBL] [Abstract][Full Text] [Related]
13. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
14. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
[TBL] [Abstract][Full Text] [Related]
15. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
[TBL] [Abstract][Full Text] [Related]
16. Chlorambucil synergizes with purine analogs in inducing in vitro cytotoxicity in B-cell chronic lymphocytic leukemia.
Callea I; Console G; Sculli G; Filangeri M; Messina G; Morabito F
Haematologica; 1998 Aug; 83(8):756-7. PubMed ID: 9793266
[TBL] [Abstract][Full Text] [Related]
17. Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia.
Honma Y; Niitsu N
Leuk Lymphoma; 2000 Sep; 39(1-2):57-66. PubMed ID: 10975384
[TBL] [Abstract][Full Text] [Related]
18. Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes.
Nakamaki T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Hino Ki; Tomoyasu S; Honma Y; Kasukabe T
Exp Hematol; 2002 May; 30(5):421-9. PubMed ID: 12031648
[TBL] [Abstract][Full Text] [Related]
19. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
20. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]